Clinical trial

Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis…

NCT00120744 · The Hospital for Sick Children, Other · Completed

Key facts

NCT number NCT00120744
Title Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
Official title Randomized Trial of the Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Acute Gastroenteritis in a Pediatric Emergency Department
Lead sponsor The Hospital for Sick Children, Other
Collaborators National Center for Research Resources (NCRR) NIH GlaxoSmithKline Industry Ann & Robert H Lurie Children's Hospital of Chicago
Status Completed
Study type Interventional
Conditions Gastroenteritis, Vomiting, Diarrhea, Dehydration
Intervention type Drug
Interventions Ondansetron Oral Disintegrating Tablet
Start date Jan 1, 2004
Primary completion Apr 1, 2005
Completion Apr 1, 2005
First posted Jul 19, 2005
Last update posted Apr 17, 2018

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies